Press releaseGlobe Newswire
Marker Therapeutics
MRKR · NASDAQ
$1.16−$0.04 (−3.33%)TodayMarket closed ·
Prev close $1.20
About MRKR
- Employees
- 5
- Headquarters
- Houston, Texas
- Listed
- Nov 8, 2016
- Sector
- Health Care
- Industry
- Biotechnology
- Website
- markertherapeutics.com
MRKR key statistics
- Market cap
- 19.34M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 161.95K
- Volume
- 209.23K
- Open price
- $1.19
- High today
- $1.24
- Low today
- $1.11
- 52 Week high
- $2.46
- 52 Week low
- $0.84
Marker Therapeutics (MRKR) at a glance
As of Oct 20, 2026, Marker Therapeutics (MRKR) shares are priced at $1.16, giving the company a market cap of 19.34M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $1.11 and $1.24. The current price is 4.5% above the day's low and 6.5% below its high.
Volume so far is 209.23K shares, above the average of 161.95K shares a day.
Over the past year Marker Therapeutics has ranged from $0.84 to $2.46, and now sits 20% of the way up that range.
Marker Therapeutics met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported -$0.09 per share against an estimate of -$0.221.
The average analyst price target is $8.02, 591.7% above the current price, from 1 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
100%of 1 analyst rating say Buy
- Buy100.0%
- Hold0.0%
- Sell0.0%
Price target · 5 analystsAvg $8.02
- Low
- $5.66
- Now
- $1.16
- High
- $10.50
MRKR earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 7 of the last 8 quarters, by 42.3% on average.
- Q3 FY24: reported -$0.26 per share against an estimate of -$0.3978
- Q4 FY24: reported -$0.42 per share against an estimate of -$0.2239
- Q1 FY25: reported -$0.36 per share against an estimate of -$0.5003
- Q2 FY25: reported -$0.29 per share against an estimate of -$0.4182
- Q3 FY25: reported -$0.12 per share against an estimate of -$0.459
- Q4 FY25: reported -$0.09 per share against an estimate of -$0.2006
- Q1 FY26: reported -$0.16 per share against an estimate of -$0.187
- Q2 FY26: reported -$0.09 per share against an estimate of -$0.221
MRKR news
- Press releaseGlobe Newswire
Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies
- Press releaseGlobe Newswire
Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results
- Press releaseGlobe Newswire
Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
- Press releaseGlobe Newswire
Good Morning America Features Baylor College of Medicine Pancreatic Cancer Study Utilizing Marker Therapeutics' MAR-T Cell Technology
- Press releaseGlobe Newswire
Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer
- Press releaseGlobe Newswire
Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
- Press releaseGlobe Newswire
Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors
Similar companies
Companies in the same industry as Marker Therapeutics
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.